Cargando…
Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is one of the hematological malignancies. With the applications of chemotherapy regimens and allogeneic hematopoietic stem cell transplantation, the cure rate of T-ALL has been significantly improved. However, patients with relapsed and refractory T-ALL st...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664086/ https://www.ncbi.nlm.nih.gov/pubmed/33292596 http://dx.doi.org/10.1186/s40164-020-00187-x |